Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|August 30, 2002
Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia Study (MLL96)Keiichi Isoyama, Mariko Eguchi, Shigeyoshi Hibi, et al.
Journal of Human Genetics|August 20, 2024
Hydrops fetalis due to loss of function of hNav1.4 channel via compound heterozygous variantsTomoya Kubota, Miho Nagata, Kazuko Takagi, et al.
Blood|December 25, 2014
Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemiaYuki Aoki, Takashi Watanabe, Yoriko Saito, et al.
Ebiomedicine|February 13, 2021
Targeting critical kinases and anti-apoptotic molecules overcomes steroid resistance in MLL-rearranged leukaemiaAnne P de Groot, Yoriko Saito, Eiryo Kawakami, et al.
Nature Communications|August 26, 2025
Multi-omics analysis identifies an M-MDSC-like immunosuppressive phenotype in lineage-switched AML with KMT2A rearrangementTakashi Mikami, Itaru Kato, Akira Nishimura, et al.
Brain & Development|June 8, 2020
Survey of patients with spinal muscular atrophy on the island of Shikoku, JapanKentaro Okamoto, Takahiro Motoki, Isao Saito, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 22, 2022
Machine learning for rhabdomyosarcoma histopathologyArthur O Frankel, Melvin Lathara, Celine Y Shaw, et al.
Blood|December 29, 2025
Comprehensive Molecular and Functional Analysis of NUTM1-Rearranged LeukemiaKoutarou Nishimura, Tomoya Isobe, Tsukasa Shigehiro, et al.
Nature Communications|August 30, 2022
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemiaTomoya Isobe, Masatoshi Takagi, Aiko Sato-Otsubo, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very youngShunsuke Kimura, Petri Polonen, Lindsey Montefiori, et al.
Pageof 9